ADA Scientific Sessions 2025 Abstract·13 JunUse of High-Potency GLP-1 Receptor Agonists with OpenAPS Automated Insulin Dosing Algorithm Eliminates Need for Meal Announcements to Achieve Glycemic GoalsStudy in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunThe Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 DiabetesReviewBiomarkersPaper